Our Products

See our range of cfDNA products below.

Pre-Analytical

Ensuring successful cfDNA analysis is our focus

Every sample is precious and to get the most out of your sample when evaluating cfDNA it is really critical to have processed your samples correctly from blood collection through to extracted cfDNA. Learn more about our Cell3 Preserver blood tube and Cell3 Xtract kit below.

Prenatal Healthcare

Non-invasive prenatal testing requires sensitive, reproducible and easy to use products.

Nonacus continues to develop innovative products to meet these exacting standards including tests for fetal rhesus-D genotyping, fetal fraction quantitation and single gene disorder testing.

Oncology

Efficient workflow enables confident calling of all ctDNA mutations

Nonacus are working with some of the brightest scientists and clinicians by providing a validated complete workflow for liquid biopsy analysis. With the ultimate goal of enabling better cancer care through earlier diagnosis, treatment stratification and monitoring.

Who we are

Designed by scientists, for Scientists

We are formed of a committed group of biotechnology professionals with a combined 35 years experience in genomic healthcare. We understand the pressure on laboratories to deliver progress and our products are designed to get you there. Between us, we’ve got global experience of genomic healthcare from the NHS in the UK through to an international genome project.

Designed by scientists
True Innovation

What we stand for

True Innovation That Benefits Patients

We translate research into routine diagnostic tools that directly benefit patients and scientists. Our non-invasive cell free DNA solutions improve diagnostic accuracy as well as the patient’s experience. Our research & development team are constantly developing, validating and testing new cfDNA products.

Built For Labs That Do

Universities

We supply Universities with our cfDNA products to help them improve their understanding and research in non-invasive healthcare.

Hospitals

Leading hospitals have adopted our products to help improve patient care through the innovative use of cfDNA technology allowing for non-invasive diagnostics.

Research Facilities

We partner with many leading laboratories to constantly innovate and push our products further.

Research Facilities

Read Our Latest Insights

Non-invasive fetal Rhesus D blood genotyping

June 11, 2021

Non-invasive prenatal testing (NIPT) using cell-free fetal DNA in maternal plasma is being used to determine fetal RhD blood group antigen status so that RhD-negative pregnant women can avoid receiving antenatal anti-D if they are carrying a RhD-negative baby.

Read More

Introducing Whole Genome Sequencing service

March 8, 2021

Government regulations, recently announced in the UK, now require Whole Genome Sequencing to be carried out as part of the minimum standards for COVID-19 tests for people arriving in England. In order to support SARS-CoV-2 testing laboratories, we have introduced a Whole Genome Sequencing service.

Read More

Nonacus. What’s behind the name?

December 18, 2020

When Chris Sale and Lee Silcock founded Nonacus in 2015 they had one singular purpose- to develop non-invasive DNA tests that would change the way genomic diagnostics was done. Choosing a name that would reflect this mission wasn’t easy. Find out why they went with ‘Nonacus’.

Read More

Are you ready to innovate your cfDNA capability?

Contact us for a quote.